• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血糖控制对2型糖尿病合并糖尿病相关性血脂异常患者的影响。

The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia.

作者信息

Abdel-Gayoum Abdel-Gayoum A

机构信息

Department of Laboratory, Dammam College of Health Sciences, PO Box 3761, Dammam 31481, Kingdom of Saudi Arabia.

出版信息

Saudi Med J. 2004 Feb;25(2):207-11.

PMID:14968220
Abstract

OBJECTIVE

The study was planned to investigate whether the serum lipid profile in type 2 diabetes mellitus was different between groups of patients classified as having good, satisfactory or poor glycemic controls, depending on their serum fructosamine levels.

METHODS

The study was carried out in the Department of Laboratory, Dammam College for Health Sciences, Dammam, Kingdom of Saudi Arabia between February 2003 to June 2003. Clinical laboratory data from diagnosed type 2 diabetic patients were used in the study. One hundred and nineteen patient's data were randomly selected, and according to their serum fructosamine levels, the patients were divided into 3 groups: 29 patients classified as patients with good glycemic control (GGC) with serum fructosamine level <250 micromol/L, 44 patients classified as satisfactory glycemic control (SGC) with serum fructosamine level ranging between 250-355 micromol/L and 46 patients classified as poor glycemic control (PGC) with serum fructosamine >355 micromol/L. The fasting serum glucose and various lipids and lipoprotein concentrations of each group were analyzed by one way analysis of variance and regression analysis.

RESULTS

In the PGC group, the serum total cholesterol (6.11+/- 1.56 mmol/l), triglyceride (2.13 +/- 0.71 mmol/L) and very low density lipoprotein-cholesterol (1.09 +/- 0.40 mmol/L) concentrations were significantly higher than that of the SGC (5.59 +/- 0.89, 1.59 +/- 0.38 and 0.86 +/- 0.28 mmol/L,), and the GGC (5.11 +/- 1.06, 1.25 +/- 0.32 and 0.78 +/- 0.29 mmol/L), whereas, those of the SGC were slightly raised, but not statistically significant, compared to the GGC. The high density lipoprotein cholesterol was significantly lower, and the low density lipoprotein cholesterol was elevated in both satisfactory and poorly controlled groups compared to good control group. Significant correlations were evident between the serum fructosamine and glucose concentrations (r=0.79, p<0.0001), and between them as independent parameters and the serum lipid concentrations.

CONCLUSION

The glycemic control in type 2 diabetes significantly improves diabetic related dyslipidemia, and would be expected to reduce the risk of atherosclerosis. It is also worth mentioning that the serum fructosamine measure gives a good index for the glycemic control, and its value can reflect the profile of serum lipids.

摘要

目的

本研究旨在调查根据血清果糖胺水平分类为血糖控制良好、满意或不佳的2型糖尿病患者组之间的血脂谱是否存在差异。

方法

该研究于2003年2月至2003年6月在沙特阿拉伯王国达曼健康科学学院实验室进行。研究使用了已确诊的2型糖尿病患者的临床实验室数据。随机选择119例患者的数据,并根据他们的血清果糖胺水平将患者分为3组:29例血清果糖胺水平<250微摩尔/升的患者被分类为血糖控制良好(GGC)组,44例血清果糖胺水平在250 - 355微摩尔/升之间的患者被分类为血糖控制满意(SGC)组,46例血清果糖胺>355微摩尔/升的患者被分类为血糖控制不佳(PGC)组。通过单因素方差分析和回归分析对每组的空腹血清葡萄糖以及各种脂质和脂蛋白浓度进行分析。

结果

在PGC组中,血清总胆固醇(6.11±1.56毫摩尔/升)、甘油三酯(2.13±0.71毫摩尔/升)和极低密度脂蛋白胆固醇(1.09±0.40毫摩尔/升)浓度显著高于SGC组(5.59±0.89、1.59±0.38和0.86±0.28毫摩尔/升)以及GGC组(5.11±1.06、1.25±0.32和0.78±0.29毫摩尔/升),而SGC组与GGC组相比略有升高,但无统计学意义。与良好控制组相比,满意和控制不佳组的高密度脂蛋白胆固醇显著降低,低密度脂蛋白胆固醇升高。血清果糖胺与葡萄糖浓度之间(r = 0.79,p<0.0001)以及它们作为独立参数与血清脂质浓度之间存在显著相关性。

结论

2型糖尿病中的血糖控制可显著改善糖尿病相关的血脂异常,并有望降低动脉粥样硬化风险。还值得一提的是,血清果糖胺测量为血糖控制提供了一个良好指标,其值可反映血脂谱。

相似文献

1
The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia.血糖控制对2型糖尿病合并糖尿病相关性血脂异常患者的影响。
Saudi Med J. 2004 Feb;25(2):207-11.
2
Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.辛伐他汀对2型糖尿病患者的降脂作用。
Indian Heart J. 2001 Mar-Apr;53(2):172-6.
3
Comparison of serum fructosamine and blood glucose concentrations as indices of glycaemic control in non-insulin dependent diabetic out-patients.非胰岛素依赖型糖尿病门诊患者中血清果糖胺和血糖浓度作为血糖控制指标的比较
Singapore Med J. 1992 Jun;33(3):287-9.
4
Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.血清果糖胺检测作为糖尿病筛查项目诊断试验的性能指标及有效性
Saudi Med J. 2003 May;24(5):477-84.
5
High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.巴基斯坦2型糖尿病患者脂蛋白(a)的高风险水平。
Saudi Med J. 2003 Jun;24(6):647-51.
6
Risk factors, knowledge and health status in diabetic patients.糖尿病患者的风险因素、知识水平及健康状况
Saudi Med J. 2003 Nov;24(11):1219-24.
7
Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.2型糖尿病患者在口服降糖药或胰岛素治疗期间的血脂谱和脂蛋白a水平比较。
Saudi Med J. 2006 Feb;27(2):174-80.
8
Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.2型糖尿病患者血清γ-谷氨酰转移酶与致动脉粥样硬化性血脂异常及血糖控制的关系
Obesity (Silver Spring). 2009 Feb;17(2):370-4. doi: 10.1038/oby.2008.544. Epub 2008 Dec 4.
9
Determination of free L-carnitine levels in type II diabetic women with and without complications.患有和未患有并发症的II型糖尿病女性游离L-肉碱水平的测定。
Eur J Clin Nutr. 2007 Jul;61(7):892-5. doi: 10.1038/sj.ejcn.1602594. Epub 2007 Feb 21.
10
Current state of metabolic control achieved in a New Zealand diabetes clinic.新西兰一家糖尿病诊所实现的代谢控制现状。
N Z Med J. 1996 Mar 22;109(1018):98-101.

引用本文的文献

1
Glycemic Effects of Rebaudioside A and Erythritol in People with Glucose Intolerance.莱鲍迪苷A和赤藓糖醇对葡萄糖不耐受人群的血糖影响。
Diabetes Metab J. 2016 Aug;40(4):283-9. doi: 10.4093/dmj.2016.40.4.283. Epub 2016 Jun 15.
2
Association of fructosamine to indices of dyslipidemia in older adults with type 2 diabetes.老年2型糖尿病患者中果糖胺与血脂异常指标的关联。
Diabetes Metab Syndr. 2011 Oct-Dec;5(4):179-82. doi: 10.1016/j.dsx.2010.12.007. Epub 2010 Dec 30.
3
Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation.
2型糖尿病患者血糖控制不佳相关的血脂异常及补充二甲双胍的保护作用。
Indian J Clin Biochem. 2012 Oct;27(4):363-9. doi: 10.1007/s12291-012-0225-8. Epub 2012 Jun 6.